Jiangsu Kangyuan Pharmaceutical Co. Ltd Report issue

For profit Phase 4
Founded: Changsha China (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2018
NCT03633890
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Jiangsu Kangyuan Pharmaceutical Co. Ltd | LIAONINGMAOKANGYUAN Biotech Co, Ltd

Active Ingredients

Drugs in Phase 4 Trials (1)

rhodiola (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1